Annual report pursuant to Section 13 and 15(d)

Document and Entity Information

Document and Entity Information - USD ($)
12 Months Ended
Apr. 30, 2015
Jul. 28, 2015
Oct. 31, 2014
Document And Entity Information [Abstract]      
Entity Registrant Name PharmaCyte Biotech, Inc.    
Entity Central Index Key 0001157075    
Document Type 10-K/A    
Document Period End Date Apr. 30, 2015    
Amendment Flag true    
Current Fiscal Year End Date --04-30    
Entity Filer Category Accelerated Filer    
Entity Common Stock, Shares Outstanding   742,610,829  
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2015    
Entity Public Float     $ 131,433,460
Entity Current Reporting Status Yes    
Entity Well Known Seasoned Issuer No    
Entity Voluntary Filers No    
Amendment Description Restatement of financial statements.